INS and type 1 diabetes mellitus: Proteomics has extensively been used to identify other circulating biomarkers [91,92], such as insulin secretory granule and mitochondrial proteins, although their presence does not necessarily correlate with an increased β-cell death or with a more aggressive T1D evolution.